Ortho Clinical Diagnostics Holdings plc

NASDAQ:OCDX   3:58:56 PM EDT
20.76
-0.51 (-2.40%)
Products

Ortho's VITROS SARS-CoV-2 Antigen Test Receives FDA Emergency Use Authorization

Published: 03/23/2021 12:12 GMT
Ortho Clinical Diagnostics Holdings plc (OCDX) - Ortho's Vitros® Sars-cov-2 Antigen Test for High-volume Testing Receives FDA Emergency Use Authorization for New Performance, Sensitivity Data.